VIDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Videx, and when can generic versions of Videx launch?
Videx is a drug marketed by Bristol and Bristol Myers Squibb and is included in four NDAs.
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIDEX?
- What are the global sales for VIDEX?
- What is Average Wholesale Price for VIDEX?
Summary for VIDEX
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Patent Applications: | 5,251 |
Drug Prices: | Drug price information for VIDEX |
What excipients (inactive ingredients) are in VIDEX? | VIDEX excipients list |
DailyMed Link: | VIDEX at DailyMed |
Paragraph IV (Patent) Challenges for VIDEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VIDEX | Capsules | didanosine | 75 mg | 020155 | 1 | 2011-06-06 |
US Patents and Regulatory Information for VIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-003 | Oct 9, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-005 | Oct 9, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-005 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-004 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-003 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-002 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIDEX
See the table below for patents covering VIDEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | 211285 | ⤷ Sign Up | |
Greece | 3026332 | ⤷ Sign Up | |
Finland | 923308 | ⤷ Sign Up | |
Finland | 105153 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VIDEX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0216510 | SPC/GB94/005 | United Kingdom | ⤷ Sign Up | SPC/GB94/005:, EXPIRES: 20070504 |
0216510 | SZ 54/1994 | Austria | ⤷ Sign Up | PRODUCT NAME: 2',3'-DIDEOXYINOSIN |
0285237 | 94C0006 | France | ⤷ Sign Up | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0216510 | 94C0006 | Belgium | ⤷ Sign Up | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |